Springe direkt zu Inhalt

Prof. Dr. Burghardt Wittig

Prof. Dr. Burghardt Wittig
Image Credit: Prof. Dr. Burghardt Wittig

Chairman

Curriculum Vitae

Academic

current

Chairman (Vorstand) Foundation Institute Molecular Biology and Bioinformatics, a non-profit foundation by Gentechnologiestiftung.

2010-2017

Chairman (Vorstand) Foundation Institute Molecular Biology and Bioinformatics, a non-profit foundation by Mologen AG and Freie Universitaet Berlin.

2003-2010

Director Institut fuer Molekularbiologie und Bioinformatik, Charité – Universitaetsmedizin Berlin (a Joint Institution of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin).

1989-2003

Department Head of Molecular Biology AND Bioinformatics at Institut fuer Molekularbiologie Und Biochemie, Freie Universitaet Berlin.

1990

Appointed Universitaetsprofessor (C4, German Full Professorship, tenure).

1.4.1989

Awarded Schering Professur (S-C4, German Full Professorship), Foundation of Chair of Molecular Biology AND BioInformatics at Freie Universitaet Berlin.

1989

Call to a Full Professorship (C4), tenure, by Freie Universitaet Berlin accepted.

1988-89

Several calls to Full Professorship (C4), tenure, rejected.

1987-89

Visiting Professor at Massachusetts Institute of Technology (MIT). Cooperation with Alexander Rich.

1987

Awarded Extraordinary Professor.

1986

Invitation by the Japanese Research Institution ERATO (Exploratory Research for Advanced Technology), Tokyo. Cooperation with Koki Horikoshi.

1984-86

Visiting Professor at Massachusetts Institute of Technology (MIT). Cooperation with Alexander Rich and Alexander Varshavsky.

1984

Invitation by the Weizmann Institute of Science, Rehovot. Cooperation with Edward Trifonov.

1983-89

Heisenberg-Fellow of Deutsche Forschungsgemeinschaft.

1983

Call to a Full Professorship (tenure) by Department of Biochemistry University of Cape Town rejected.

1982

Offer of an Associate-Professorship at Freie Universitaet Berlin rejected.

Acceptance of a Heisenberg-Fellowship from Deutsche Forschungsgemeinschaft.

1980

Habilitation for "Biochemistry and Molecular Biology".

1978

Appointed as Assistent Professor at Freie Universitaet Berlin.

1976-78

Postdoc and head of a junior research group at Freie Universitaet Berlin.

1976-86

Accompanying studies of physics (without academic degrees) as a guest student at Freie Universitaet Berlin (FUB), Technische Universitaet Berlin (TUB), California Institute of Technology (CalTech), and Massachusetts Institute of Technology (MIT).

1976

Defense of thesis on "Purification and Characterization of the Four Lysine Specific Transfer-Ribonucleicacids from Chicken Embryos".

1975

Final examination (Staatsexamen) as a physician for Human Medicine from Freie Universitaet Berlin.

During medical studies experimental work for doctoral thesis at Institut fuer Molekularbiologie und Biochemie of Freie Universitaet Berlin and at Max-Planck-Institut fuer Molekulare Genetik in Berlin by supervision of H. Gottschling, V.A. Erdmann, O. Pongs, H.-J. Risse, H. Tiedemann, und H. G. Wittmann.

1968

Enrollment as a medical student at Freie Universitaet Berlin.

Education and diploma at German school of hearing aid technicians and work in parents business.

Accompanying studies of physics (without academic degrees) at California Institute of Technology (CalTech).

Business

current

Senior Advisor to MOLOGEN AG

2008-2014

Chairman of Scientific and Strategic Advisory Board of MOLOGEN AG.

1998-2007

CEO of MOLOGEN AG (1998-2002 Mologen Holding AG).

1998

Foundation of Mologen Holding AG in Berlin, Germany. Merger of Soft Gene GmbH and Mologen GmbH into Mologen Holding AG.

IPO at German stock exchange June 1998.

1997

Foundation of Mologen GmbH in Hamburg, Germany.

1995

Organizer and scientific director of the treatment and research institution "Center for Somatic Gene Therapy".

1989

Foundation of Soft Gene Entwicklungs- und Vertriebsgesellschaft für molekularbiologische Software mbH as a bioinformatic research spin-off.

Potential Conflict of Interest

Prof. Wittig advises MOLOGEN AG against reimbursement of expenses. MOLOGEN Foundation Institute Molecular Biology and Bioinformatics receives funding by MOLOGEN AG.